JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo RIUMAComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentrosDepartamentos/InstitutosEditores

    Mi cuenta

    AccederRegistro

    Estadísticas

    Ver Estadísticas de uso

    DE INTERÉS

    Datos de investigaciónReglamento de ciencia abierta de la UMAPolítica de RIUMAPolitica de datos de investigación en RIUMAOpen Policy Finder (antes Sherpa-Romeo)Dulcinea
    Preguntas frecuentesManual de usoContacto/Sugerencias
    Listar por autor 
    •   RIUMA Principal
    • Listar por autor
    •   RIUMA Principal
    • Listar por autor

    Listar por autor "Segovia-Zafra, Antonio"

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Ordenar por:

    Orden:

    Resultados:

    Mostrando ítems 1-6 de 6

    • título
    • fecha de publicación
    • fecha de envío
    • ascendente
    • descendente
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network 

        Segovia-Zafra, Antonio; Villanueva-Paz, Marina; Serras, Ana Sofía; Matilla-Cabello, Gonzalo; Bodoque-García, Ana; Di Zeo-Sánchez, Daniel Enrique; Niu, Hao; Álvarez-Álvarez, Ismael; Sanz-Villanueva, Laura; Godec, Sergej; Milisav, Irina; Bagnaninchi, Pierre; Andrade, Raúl J.; Lucena, M. Isabel; Fernandez-Checa, J.C.; Cubero, Francisco Javier; Paiva Miranda, Joana; Nelson, Leonard J.[et al.] (Elsevier, 2024)
        Background & Aims Idiosyncratic drug-induced liver injury (DILI) is a complex and unpredictable event caused by drugs, and herbal or dietary supplements. Early identification of human hepatotoxicity at preclinical stages ...
      • Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions 

        Villanueva-Paz, Marina; Niu, Hao; Segovia-Zafra, Antonio; Medina-Cáliz, InmaculadaAutoridad Universidad de Málaga; Sanabria-Cabrera, Judith AdrianaAutoridad Universidad de Málaga; Lucena-González, María IsabelAutoridad Universidad de Málaga; Andrade-Bellido, Raúl JesúsAutoridad Universidad de Málaga; Alvarez-Alvarez, Ismael; Sanabria-Cabrera, Judith AdrianaAutoridad Universidad de Málaga[et al.] (MDPI, 2021-11-15)
        Drug-induced liver injury (DILI) encompasses the unexpected damage that drugs can cause to the liver. DILI may develop in the context of an immunoallergic syndrome with cutaneous manifes- tations, which are sometimes severe ...
      • Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions 

        Cueto Sánchez, Alejandro José; Di Zeo-Sánchez, Daniel Enrique; Segovia-Zafra, Antonio; Matilla-Cabello, Gonzalo; Bodoque-García, Ana; Lucena-González, María IsabelAutoridad Universidad de Málaga; Villanueva-Paz, Marina[et al.] (Open Exploration, 2023-04-26)
        The late event onset of a fraction of idiosyncratic drug-induced liver injury (DILI) cases and the link observed by genome-wide association studies (GWASs) of certain human leucocyte antigen (HLA) alleles with DILI due to ...
      • Modeling drug-induced liver injury: current status and future prospects. 

        Di Zeo-Sánchez, Daniel Enrique; Segovia-Zafra, Antonio; Matilla-Cabello, Gonzalo; Pinazo-Bandera, José; Andrade-Bellido, Raúl JesúsAutoridad Universidad de Málaga; Lucena-González, María IsabelAutoridad Universidad de Málaga; Villanueva-Paz, Marina[et al.] (Taylor & Francis, 2022-09-16)
        Introduction Idiosyncratic drug-induced liver injury (iDILI) is a challenging and unpredictable multifactorial condition. At present, validated preclinical models for the prediction of the hepatotoxic potential of a given ...
      • Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction 

        Segovia-Zafra, Antonio; Di Zeo-Sánchez, Daniel Enrique; López-Gómez, Carlos; Pérez-Valdés, Zeus; García-Fuentes, Eduardo; Andrade-Bellido, Raúl JesúsAutoridad Universidad de Málaga; Lucena-González, María IsabelAutoridad Universidad de Málaga; Villanueva-Paz, Marina[et al.] (Elsevier, 2021-12)
        Idiosyncratic drug-induced liver injury (iDILI) encompasses the unexpected harms that pre- scription and non-prescription drugs, herbal and dietary supplements can cause to the liver. iDILI remains a major public health ...
      • Recreational Drugs and the Risk of Hepatocellular Carcinoma 

        Pinazo-Bandera, José M.; García-Cortés, MirenAutoridad Universidad de Málaga; Segovia-Zafra, Antonio; Lucena-González, María IsabelAutoridad Universidad de Málaga; Andrade-Bellido, Raúl JesúsAutoridad Universidad de Málaga (IOAP-MPDI, 2022-11-02)
        Hepatocellular carcinoma represents an important contributor to the global cancer-related burden, and liver cirrhosis is the main risk factor for its development. Conventional or illegal drug consumption is a potential but ...
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
         

         

        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA